Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page
- Check7 days agoChange DetectedThe revision is updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no substantive content changes were detected.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, and the 'Back to Top' feature has been added.SummaryDifference0.1%
- Check21 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as detailed drug information for Resmetirom, which is significant for users seeking treatment options for Fatty Liver Disease. Additionally, several outdated location entries have been removed.SummaryDifference13%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.8 to version 2.16.11, indicating a revision in the content.SummaryDifference0.0%
- Check50 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.8, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.